BZAM Ltd.

Healthcare US BZAMF

NoneUSD
0.00(0%)

Last update at 2025-11-27T20:03:50.973567Z

Day Range

LowHigh

52 Week Range

0.080.37

LowHigh

Fundamentals

Previous Close -
Market Cap20.35M
VolumeNone
P/E Ratio-
Dividend Yield-%
EBITDA-47.16100M
Revenue TTM81.65M
Revenue Per Share TTM0.52
Gross Profit TTM 30.36M
Diluted EPS TTM-0.73

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Income before tax	-36.35900M	-39.98000M	-183.35500M	-196.41600M
Minority interest	1.29M	0.16M	0.59M	-
Net income	-35.50400M	-42.13800M	-182.54100M	-195.75000M
Selling general administrative	29.26M	27.52M	39.34M	71.73M
Selling and marketing expenses	-	-	-	-
Gross profit	6.75M	11.73M	6.11M	9.54M
Reconciled depreciation	8.63M	13.75M	7.22M	4.24M
Ebit	-35.23500M	-28.35600M	-39.93700M	-68.42300M
Ebitda	-21.08700M	-14.64500M	-170.26400M	-191.96400M
Depreciation and amortization	-	-	-	-
Non operating income net other	-	-	-	-
Operating income	-31.63300M	-28.48100M	-41.84600M	-68.69300M
Other operating expenses	23.61M	8.16M	5.87M	0.43M
Interest expense	6.64M	11.58M	5.87M	0.21M
Tax provision	0.00000M	-0.43600M	-0.22400M	-0.66600M
Interest income	0.02M	0.09M	0.38M	2.82M
Net interest income	-6.61800M	-11.49300M	-5.48700M	2.60M
Extraordinary items	-	-	-	-
Non recurring	-	-	-	-
Other items	-	-	-	-
Income tax expense	-	-0.43600M	-	-0.66600M
Total revenue	49.35M	30.24M	21.50M	10.96M
Total operating expenses	80.98M	58.72M	63.34M	79.65M
Cost of revenue	42.60M	18.51M	15.38M	1.41M
Total other income expense net	1.89M	-0.00600M	-136.02200M	-130.32700M
Discontinued operations	-0.43200M	-2.75300M	-11.35300M	-11.35300M
Net income from continuing ops	-36.35900M	-39.54400M	-183.13100M	-195.75000M
Net income applicable to common shares	-35.50400M	-42.13800M	-182.54100M	-195.15500M
Preferred stock and other adjustments	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Total assets	274.44M	194.35M	211.57M	342.18M
Intangible assets	28.32M	15.59M	8.93M	12.02M
Earning assets	-	-	-	-
Other current assets	16.43M	15.67M	2.23M	11.13M
Total liab	96.13M	57.53M	71.77M	74.58M
Total stockholder equity	171.57M	137.67M	140.95M	268.15M
Deferred long term liab	-	-	-	-
Other current liab	4.30M	2.57M	0.15M	0.04M
Common stock	578.01M	508.50M	468.38M	428.65M
Capital stock	578.01M	508.50M	468.38M	428.65M
Retained earnings	-514.20100M	-478.69700M	-436.55900M	-254.01800M
Other liab	16.09M	3.42M	0.84M	1.49M
Good will	28.69M	3.94M	0.00000M	8.10M
Other assets	0.40M	1.74M	11.00M	11.94M
Cash	4.65M	4.09M	11.21M	27.57M
Cash and equivalents	-	-	-	-
Total current liabilities	42.21M	29.39M	66.38M	53.23M
Current deferred revenue	-	-	-	-
Net debt	27.97M	21.63M	29.54M	-
Short term debt	-	-	-	-
Short long term debt	5.41M	7.51M	40.76M	0.52M
Short long term debt total	-	-	-	-
Other stockholder equity	-1.72300M	-0.96900M	0.26M	-2.24100M
Property plant equipment	129.37M	117.98M	147.26M	237.03M
Total current assets	87.66M	55.11M	44.38M	68.17M
Long term investments	-	-	-	4.92M
Net tangible assets	114.55M	118.15M	132.02M	248.03M
Short term investments	-	-	-	-
Net receivables	10.74M	9.75M	10.18M	10.04M
Long term debt	27.21M	18.20M	-	16.91M
Inventory	52.42M	24.09M	19.12M	11.04M
Accounts payable	29.51M	17.66M	24.45M	52.07M
Total permanent equity	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-
Accumulated other comprehensive income	-	-	-	-
Additional paid in capital	-	-	-	-
Common stock total equity	-	-	-	-
Preferred stock total equity	-	-	-	-
Retained earnings total equity	-	-	-	-
Treasury stock	-	-	-	-
Accumulated amortization	-	-	-	-
Non currrent assets other	0.40M	1.74M	11.00M	11.94M
Deferred long term asset charges	-	-	-	-
Non current assets total	186.78M	139.24M	167.19M	274.01M
Capital lease obligations	12.07M	7.57M	5.57M	3.54M
Long term debt total	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Investments	4.95M	1.24M	1.24M	-1.43400M
Change to liabilities	0.00000M	4.97M	4.30M	4.96M
Total cashflows from investing activities	4.95M	25.80M	-42.17600M	-184.09400M
Net borrowings	7.17M	-25.34800M	21.00M	15.85M
Total cash from financing activities	6.84M	-13.44300M	60.47M	56.10M
Change to operating activities	22.44M	1.15M	11.88M	-5.23200M
Net income	-35.50400M	-42.13800M	-182.54100M	-195.15500M
Change in cash	0.56M	-7.12300M	-16.35700M	-185.98000M
Begin period cash flow	4.09M	11.21M	27.57M	213.55M
End period cash flow	4.65M	4.09M	11.21M	27.57M
Total cash from operating activities	-8.99400M	-18.03800M	-35.95800M	-56.69700M
Issuance of capital stock	4.80M	9.32M	43.90M	24.67M
Depreciation	8.63M	13.70M	7.19M	4.20M
Other cashflows from investing activities	0.67M	6.16M	7.96M	40.07M
Dividends paid	0.00000M	0.00000M	0.00000M	0.00000M
Change to inventory	2.74M	-2.87800M	-7.43800M	-4.64900M
Change to account receivables	6.84M	2.11M	-8.53500M	-0.28900M
Sale purchase of stock	-	-	-	-
Other cashflows from financing activities	-5.12300M	-4.97600M	3.15M	6.29M
Change to netincome	-4.56200M	5.00M	139.16M	139.44M
Capital expenditures	1.12M	9.12M	50.26M	219.65M
Change receivables	-	-	-	-
Cash flows other operating	-	-	-	-
Exchange rate changes	-	-	-	-
Cash and cash equivalents changes	-	-	-	-
Change in working capital	22.44M	5.35M	0.21M	-5.21400M
Stock based compensation	0.21M	3.38M	6.38M	14.29M
Other non cash items	-46.76400M	0.39M	1.55M	-1.99600M
Free cash flow	-10.11800M	-27.16500M	-86.50500M	-279.42900M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
BZAMF BZAM Ltd.	- -%	-	-	-	0.22	0.33	0.68	-0.5623
ZTS Zoetis Inc	-2.135 2.71%	76.58	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	-0.19 0.62%	30.56	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	157.12	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	-0.12 0.28%	42.82	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.